Injective vs ORE Protocol

Compare Injective and ORE Protocol on TVL, fees, revenue and activity to understand how these projects stack up.

Injective Perps is the perpetual futures market of Injective, a layer 1 blockchain optimized for finance. Trading runs on Injective's native onchain order book module, which offers fully onchain matching and settlement, front-running resistance through frequent batch auctions and very low fees. Markets cover major crypto assets as well as real-world assets such as equities, commodities and forex, and the shared liquidity layer is used by multiple trading front-ends built on Injective. Part of the fees feeds the INJ burn auction.
View Full Page
ORE is a fair-launched digital store of value native to Solana, distributed through an onchain mining game rather than a pre-mine or private sale. In each round, miners deploy SOL on a grid of blocks, and a winning block is chosen at random, with SOL from the losing blocks distributed to the winners along with newly minted ORE. A portion of the protocol's revenue is used to buy back ORE and reward stakers, and the token has a capped supply inspired by the scarcity model of Bitcoin.
View Full Page

Key Metrics Comparison

Injective
TVL
N/A
24h Volume
$4.43M
24h Fees
N/A
24h Revenue
N/A
30d Fees
N/A
30d Revenue
N/A
7d TVL Change
N/A
Dominance
0.00%
ORE Protocol
TVL
N/A
24h Volume
N/A
24h Fees
$121.4K
24h Revenue
$121.4K
30d Fees
$3.67M
30d Revenue
$3.67M
7d TVL Change
N/A
Dominance
0.00%

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

TVL Share

Share of combined TVL

TVL Share
Injective
1.0%
ORE Protocol
1.0%

Volume Share

Share of combined 24h volume

Volume Share
Injective
1.0%
ORE Protocol
1.0%

Fees Share

Share of combined 24h fees

Fees Share
Injective
1.0%
ORE Protocol
1.0%

Revenue Share

Share of combined 24h revenue

Revenue Share
Injective
1.0%
ORE Protocol
1.0%

7d TVL Performance

TVL change over last 7 days

7d TVL Performance
Injective
N/A
ORE Protocol
N/A

Dominance

Market dominance by TVL

Dominance
Injective
0.0%
ORE Protocol
0.0%